Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Ifosfamide × 1 year × Clear all

Sponsor

Conditions

Sarcoma 10 Lymphoma, Large B-Cell, Diffuse 9 Sarcoma, Ewing 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Osteosarcoma 4 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Hodgkin Disease 3 Sarcoma, Clear Cell 2 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Penile Neoplasms 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Lymphoma, Follicular 2 Lymphoma 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Burkitt Lymphoma 2 Wilms Tumor 1 Vascular Neoplasms 1 Teratoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1

Interventions

Cyclophosphamide 6 Etoposide 4 Prednisone 3 Doxorubicin 3 romidepsin 2 pembrolizumab 2 etoposide phosphate 2 Vincristine 2 Melphalan 2 Brentuximab Vedotin 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 sodium-iodide symporter 1 ruxolitinib 1 prednylidene 1 glofitamab 1 fludarabine phosphate 1 fludarabine 1 duvelisib 1 deltacortene 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡